Prism Medico and Pharmacy Ltd

📊 Prism Medico Q2 FY2025 Results: Revenue at ₹50.23L, Net Loss of ₹8.48L

- Revenue from Operations: ₹50.23 lakhs (quarter), ₹292.52 lakhs (year ended March 2024)

- Net Loss: ₹(8.48) lakhs (quarter), ₹(2.13) lakhs (year ended March 2024)

- Total Assets: ₹1,583.36 lakhs (as of 30th September 2025)

- Current Assets: ₹1,583.36 lakhs

- Paid-up Equity Share Capital: ₹606.34 lakhs

- Other Equity: ₹960.19 lakhs

- EPS (Basic & Diluted): ₹(0.0014) per share (quarter)

- Single-segment business (segment reporting not applicable)

- Financials reviewed by Garg Mendiratta & Associates (no material misstatements found)

- Initial filing error corrected (missing PDF statements later re-uploaded)